Exact Mass: 314.1743

Exact Mass Matches: 314.1743

Found 97 metabolites which its exact mass value is equals to given mass value 314.1743, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Magnocurarine

Isoquinolinium, 1,2,3,4-tetrahydro-7-hydroxy-1-((4-hydroxyphenyl)methyl)-6-methoxy-2,2-dimethyl-, (R)-

C19H24NO3+ (314.1756)


Magnocurarine is a member of isoquinolines. Magnocurarine is a natural product found in Lindera megaphylla, Litsea cubeba, and other organisms with data available.

   

Lotusine

Isoquinolinium, 1,2,3,4-tetrahydro-6-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-, (1R)-

C19H24NO3+ (314.1756)


Lotusine is a member of isoquinolines. Lotusine is a natural product found in Nelumbo nucifera, Magnolia officinalis, and Xylopia parviflora with data available. Quaternary alkaloid from the embryo of Nelumbo nucifera (East India lotus). Lotusine is found in coffee and coffee products. Lotusine is found in coffee and coffee products. Quaternary alkaloid from the embryo of Nelumbo nucifera (East India lotus).

   

Pergolide

(2R,4R,7R)-4-[(methylsulfanyl)methyl]-6-propyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene

C19H26N2S (314.1817)


Pergolide is a long-acting dopamine agonist approved in 1982 for the treatment of Parkinsons Disease. It is an ergot derivative that acts on the dopamine D2 and D3, alpha2- and alpha1-adrenergic, and 5-hydroxytryptamine (5-HT) receptors. It was indicated as adjunct therapy with levodopa/carbidopa in the symptomatic treatment of parkinsonian syndrome. It was later found that pergolide increased the risk of cardiac valvulopathy. The drug was withdrawn from the US market in March 2007 and from the Canadian market in August 2007. N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

Oblongine

8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C19H24NO3+ (314.1756)


Oblongine is a member of isoquinolines. Oblongine is a natural product found in Stephania cephalantha, Stephania tetrandra, and other organisms with data available. Oblongine is found in fruits. Quaternary alkaloid from stems of Litsea cubeba (mountain pepper). Quaternary alkaloid from stems of Litsea cubeba (mountain pepper). Oblongine is found in fruits.

   

Perilloside A

2-(hydroxymethyl)-6-{[4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


Constituent of Perilla frutescens (perilla). Perilloside A is found in fats and oils and herbs and spices. Perilloside A is found in fats and oils. Perilloside A is a constituent of Perilla frutescens (perilla).

   

(-)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


(-)-trans-Carveol glucoside is found in citrus. (-)-trans-Carveol glucoside is a constituent of Citrus species and ginger mint Mentha gentilis cardiaca Constituent of Citrus subspecies and ginger mint Mentha gentilis cardiaca. (-)-trans-Carveol glucoside is found in citrus.

   

(+)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1R,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


(+)-trans-Carveol glucoside is found in citrus. (+)-trans-Carveol glucoside is a constituent of Citrus species Constituent of Citrus subspecies (+)-trans-Carveol glucoside is found in citrus.

   

17-Ethynyl-16-fluoroestradiol

17-ethynyl-16-fluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

C20H23FO2 (314.1682)


   

N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine

3-({3-methyl-1-[(3-methylbutyl)-C-hydroxycarbonimidoyl]butyl}-C-hydroxycarbonimidoyl)oxirane-2-carboxylate

C15H26N2O5 (314.1842)


   

Resiquimod

1-[2-(ethoxymethyl)-4-imino-1H,4H,5H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol

C17H22N4O2 (314.1743)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent

   

3,3,6-Trimethyl-5-heptene-1,2,4-triol

3,3,6-Trimethyl-5-heptene-1,2,4-triol

C16H26O6 (314.1729)


   
   

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

myrtenol 10-O-beta-D-glucopyranoside|myrtenyl 10-O-beta-D-glucopyranoside|myrtenyl O-beta-D-glucopyranoside

myrtenol 10-O-beta-D-glucopyranoside|myrtenyl 10-O-beta-D-glucopyranoside|myrtenyl O-beta-D-glucopyranoside

C16H26O6 (314.1729)


   

limonen-10-ol 10-O-beta-D-glucopyranoside|Limonene-10-ol 10-O-??-D-glucopyranoside

limonen-10-ol 10-O-beta-D-glucopyranoside|Limonene-10-ol 10-O-??-D-glucopyranoside

C16H26O6 (314.1729)


   

(-)-cis-chrysanthenol-beta-D-galactopyranoside

(-)-cis-chrysanthenol-beta-D-galactopyranoside

C16H26O6 (314.1729)


   

seco-dihydropyrenophorin-1,4-lactone

seco-dihydropyrenophorin-1,4-lactone

C16H26O6 (314.1729)


   

manadoperoxide C

manadoperoxide C

C16H26O6 (314.1729)


   

1,3,5-triphenylpentan-1-one

1,3,5-triphenylpentan-1-one

C23H22O (314.1671)


   

p-menth-1(7),4(8)-diene-3-yl beta-D-glucopyranoside

p-menth-1(7),4(8)-diene-3-yl beta-D-glucopyranoside

C16H26O6 (314.1729)


   

3alpha,4alpha,8alpha-trihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6,12-olide

3alpha,4alpha,8alpha-trihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6,12-olide

C16H26O6 (314.1729)


   

p-mentha-1(7),8-dien-2-O-beta-D-glucoside

p-mentha-1(7),8-dien-2-O-beta-D-glucoside

C16H26O6 (314.1729)


   

peroxyplakoric ester C

peroxyplakoric ester C

C16H26O6 (314.1729)


   

(-)-trans-verbenol beta-D-glucopyranoside

(-)-trans-verbenol beta-D-glucopyranoside

C16H26O6 (314.1729)


   

O=C(CCCCC(=O)O)CCCCC(CCCCC(=O)O)=O

O=C(CCCCC(=O)O)CCCCC(CCCCC(=O)O)=O

C16H26O6 (314.1729)


   
   

L-trans-Epoxysuccinyl-Leu-3-methylbutylamide

L-trans-Epoxysuccinyl-Leu-3-methylbutylamide

C15H26N2O5 (314.1842)


   

Pergolide

Pergolide

C19H26N2S (314.1817)


N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist relative retention time with respect to 9-anthracene Carboxylic Acid is 0.736 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.732 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.731

   

p-Hydroxyminaprine

p-Hydroxyminaprine

C17H22N4O2 (314.1743)


   

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

C16H26O6 (314.1729)


   

Granisetron metabolite 4

Granisetron metabolite 4

C17H22N4O2 (314.1743)


   

E-64c

(2S,3S)-3[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-oxiranecarboxylic acid

C15H26N2O5 (314.1842)


   

(-)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(+)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1R,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

Lotusine

6-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C19H24NO3 (314.1756)


   

Perilloside A

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(4S)-4-isopropenyl-1-cyclohexenyl]methoxy]tetrahydropyran-3,4,5-triol

C16H26O6 (314.1729)


   

Oblongine

8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C19H24NO3+ (314.1756)


   

3-PHENYL-1-(PYRIDIN-2-YL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA[C]PYRIDINE

3-PHENYL-1-(PYRIDIN-2-YL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA[C]PYRIDINE

C22H22N2 (314.1783)


   

Moxiraprine

Moxiraprine

C17H22N4O2 (314.1743)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

1-(4-Methoxybenzyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-(4-Methoxybenzyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

C17H23BN2O3 (314.1802)


   

4-isopropyl-2,5-dioxoimidazolidine-1,3-di(propionohydrazide)

4-isopropyl-2,5-dioxoimidazolidine-1,3-di(propionohydrazide)

C12H22N6O4 (314.1702)


   

butyl prop-2-enoate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid

butyl prop-2-enoate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid

C16H26O6 (314.1729)


   

dibutyl (Z)-but-2-enedioate,ethenyl acetate

dibutyl (Z)-but-2-enedioate,ethenyl acetate

C16H26O6 (314.1729)


   

4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene

4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene

C17H27ClO3 (314.1649)


   

hc yellow no. 7

hc yellow no. 7

C17H22N4O2 (314.1743)


   

butyl prop-2-enoate,ethenyl acetate,methyl 2-methylprop-2-enoate

butyl prop-2-enoate,ethenyl acetate,methyl 2-methylprop-2-enoate

C16H26O6 (314.1729)


   

SODIUM HEXETH-4 CARBOXYLATE

SODIUM HEXETH-4 CARBOXYLATE

C14H27NaO6 (314.1705)


   

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)-1H-PYRAZOLE

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)-1H-PYRAZOLE

C17H23BN2O3 (314.1802)


   

5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

C17H22N4O2 (314.1743)


   

butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid

butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid

C16H26O6 (314.1729)


   
   

2-(Aminomethyl)phenol

2-(Aminomethyl)phenol

C17H22N4O2 (314.1743)


   

BIS(4-(VINYLOXY)BUTYL) SUCCINATE

BIS(4-(VINYLOXY)BUTYL) SUCCINATE

C16H26O6 (314.1729)


   

Dimethocaine hydrochloride

Dimethocaine hydrochloride

C16H27ClN2O2 (314.1761)


   

Fluoxetine-d5 solution

Fluoxetine-d5 solution

C17H13D5F3NO (314.1654)


   

Sildenafil Impurity

Sildenafil Impurity

C17H22N4O2 (314.1743)


   

Pentaethylene glycol monophenyl ether

Pentaethylene glycol monophenyl ether

C16H26O6 (314.1729)


   

Poly(oxy-1,2-ethanediyl), alpha,alpha-1,6-hexanediylbis(omega-((1-oxo-2-propenyl)oxy)

Poly(oxy-1,2-ethanediyl), alpha,alpha-1,6-hexanediylbis(omega-((1-oxo-2-propenyl)oxy)

C16H26O6 (314.1729)


   

(2S,5S)-ethyl 1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylate

(2S,5S)-ethyl 1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylate

C15H26N2O5 (314.1842)


   

(2,3-dipentylphenyl) dihydrogen phosphate

(2,3-dipentylphenyl) dihydrogen phosphate

C16H27O4P (314.1647)


   

Ralmitaront

Ralmitaront

C17H22N4O2 (314.1743)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ralmitaront (RO6889450) is an orally active agonist of trace amine-associated receptor 1 (TAAR1) with a EC50 value of 110.4 nM. Ralmitaront has antipsychotic, cognitively improvement, and antidepressant activity in rodents. Ralmitaront can be used as a neurosuppressant in the study of neuro-related diseases, such as schizophrenia (SCZ), schizoaffective disorder[1][2][3][4].

   

Ethidium

Ethidium

C21H20N3+ (314.1657)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors

   

Lotusine

Isoquinolinium, 1,2,3,4-tetrahydro-6-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-, (1R)-

C19H24NO3+ (314.1756)


Lotusine is a member of isoquinolines. Lotusine is a natural product found in Nelumbo nucifera, Magnolia officinalis, and Xylopia parviflora with data available.

   

2-(4-Ethenyl-2,5-dimethylhexa-2,5-dienoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-(4-Ethenyl-2,5-dimethylhexa-2,5-dienoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol

C19H24NO3+ (314.1756)


   

1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-7-ol

1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-7-ol

C19H24NO3+ (314.1756)


   

N-cyclohexyl-1-(4-fluorophenyl)-2,5-dimethyl-3-pyrrolecarboxamide

N-cyclohexyl-1-(4-fluorophenyl)-2,5-dimethyl-3-pyrrolecarboxamide

C19H23FN2O (314.1794)


   

N-[2-(dimethylamino)ethyl]-2-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]acetamide

N-[2-(dimethylamino)ethyl]-2-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]acetamide

C17H22N4O2 (314.1743)


   

(5R,8R)-8-methyl-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5R,8R)-8-methyl-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C17H22N4O2 (314.1743)


   

(4R,7R)-4-methyl-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7R)-4-methyl-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C17H22N4O2 (314.1743)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C15H26N2O5 (314.1842)


   
   

(6aR,9S,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline

(6aR,9S,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline

C19H26N2S (314.1817)


   

N-[(1-ethylpyrrolidin-2-yl)methyl]-8-fluoro-5H-pyrimido[5,4-b]indol-3-ium-4-amine

N-[(1-ethylpyrrolidin-2-yl)methyl]-8-fluoro-5H-pyrimido[5,4-b]indol-3-ium-4-amine

C17H21FN5+ (314.1781)


   

2-[(3-Butoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Butoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C12H29NO6P+ (314.1732)


   

Resiquimod

Resiquimod

C17H22N4O2 (314.1743)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent

   
   

(2r,3r,4s,5s,6r)-2-{[(1r,5s)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,5s)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,5r)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,5r)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2r,4s)-1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

(2r,4s)-1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

C16H26O6 (314.1729)


   

4-(5-oxooxolan-2-yl)butan-2-yl 4,7-dihydroxyoct-2-enoate

4-(5-oxooxolan-2-yl)butan-2-yl 4,7-dihydroxyoct-2-enoate

C16H26O6 (314.1729)


   

4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

C16H26O6 (314.1729)


   

2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

C16H26O6 (314.1729)


   

(2r)-4-(5-oxooxolan-2-yl)butan-2-yl (2e,4s,7r)-4,7-dihydroxyoct-2-enoate

(2r)-4-(5-oxooxolan-2-yl)butan-2-yl (2e,4s,7r)-4,7-dihydroxyoct-2-enoate

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(4s)-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(4s)-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-2-en-1-yl}oxy)oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-2-en-1-yl}oxy)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(5r,8r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-3-ene-2,10-dione

(5r,8r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-3-ene-2,10-dione

C16H26O6 (314.1729)


   

2-(hydroxymethyl)-6-{[2-(4-methylcyclohex-3-en-1-yl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[2-(4-methylcyclohex-3-en-1-yl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(1r)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

(1r)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C19H24NO3]+ (314.1756)


   

7-hydroxy-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

7-hydroxy-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C19H24NO3]+ (314.1756)


   

(3r,4s,4ar,5s,8as)-4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

(3r,4s,4ar,5s,8as)-4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

C16H26O6 (314.1729)


   

(2r,3s,4r,7r)-2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

(2r,3s,4r,7r)-2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

C16H26O6 (314.1729)


   

(1s)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

(1s)-8-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C19H24NO3]+ (314.1756)


   

2-(hydroxymethyl)-6-{[2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

2-({6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)